Naproxen Hualan Pharmaceuticals (Naproxen)

Naproxen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 (COX‑1/COX‑2) enzymes. This inhibition blocks the conversion of arachidonic acid to prostaglandins, which are mediators of pain, inflammation, and fever. By lowering prostaglandin levels, naproxen reduces these symptoms.

The appropriate dose of naproxen is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and renal or hepatic function. Dosage regimens can vary widely, so patients should follow the specific instructions provided by their prescriber.

Safety data for naproxen during pregnancy and lactation are limited. It is generally avoided in the third trimester because of potential fetal cardiovascular effects, and caution is advised during breastfeeding. Women who are pregnant, planning pregnancy, or nursing should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen has a longer half‑life, allowing twice‑daily dosing, whereas ibuprofen often requires three‑four times daily dosing. Individual response, gastrointestinal tolerance, and specific cardiovascular risk profiles influence the choice between them.

Naproxen tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Naproxen is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should swallow tablets whole and not crush or chew them unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding, ulcer perforation, cardiovascular events such as heart attack or stroke, and renal impairment. Rare but severe skin reactions like Stevens‑Johnson syndrome may also occur. Patients should seek immediate medical attention if they notice signs of bleeding, chest pain, sudden kidney problems, or severe skin rash.

Naproxen should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in patients who have recently undergone coronary artery bypass graft surgery.